Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer - Contacts and Locations

Home

Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer

This study is ongoing, but not recruiting participants.

Study NCT00006368. Last updated on July 23, 2008. Information provided by National Cancer Institute (NCI)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00006368

Locations


United States, Florida
	H. Lee Moffitt Cancer Center and Research Institute
	Tampa, Florida, United States, 33612-9497

Sponsors and Collaborators

H. Lee Moffitt Cancer Center and Research Institute

Investigators


Study Chair:	Larry K. Kvols, MD	H. Lee Moffitt Cancer Center and Research Institute